WOLVERINE ASSET MANAGEMENT LLC - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 62 filers reported holding BIOTECH ACQUISITION COMPANY in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$2,240
+12.0%
35,0560.0%0.00%
Q3 2022$2,000
-33.3%
35,0560.0%0.00%
Q2 2022$3,000
-62.5%
35,056
+1.5%
0.00%
Q1 2022$8,000
-63.6%
34,5420.0%0.00%
Q4 2021$22,000
-35.3%
34,542
-33.1%
0.00%
Q3 2021$34,000
-37.0%
51,630
-19.1%
0.00%
Q2 2021$54,00063,7960.00%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q4 2021
NameSharesValueWeighting ↓
Kingstown Capital 300,000$72,0000.11%
Telemetry Investments, L.L.C. 153,694$36,0000.06%
Kamunting Street Capital Management, L.P. 158,962$38,0000.05%
Radcliffe Capital Management, L.P. 202,950$2,001,0000.04%
Q Global Advisors, LLC 300,000$72,0000.04%
Integrity Capital Management (HK) Ltd 33,267$8,0000.04%
Corbin Capital Partners, L.P. 464,062$111,0000.02%
HGC Investment Management Inc. 1,215,782$292,0000.02%
Segantii Capital Management Ltd 50,000$493,0000.01%
Sage Rock Capital Management LP 286,900$69,0000.01%
View complete list of BIOTECH ACQUISITION COMPANY shareholders